Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ·Healthcare·Biotechnology
$509.96
-1.24%
Mkt Cap $131.05B
Analyst Ratings
Buy
12
Hold
3
Sell
1
Price Target (106 analysts)
$559.33
Range $350.00 – $665.00
Implied Upside
+9.7%
Consensus $559.33 vs current $509.96